Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level650 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02163291 | Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer | unknown | Phase 2 | 30 | Peking UniversityOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT00991952 | Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 26, 2014 | clinicaltrials |
| NCT00183911 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | completed | Phase 2 | 25 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01379482 | Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer | completed | Phase 2 | 18 | Uppsala UniversityOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01444521 | Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer | completed | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | completed | Phase 1 / Phase 2 | 86 | Chinese PLA General HospitalOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01672333 | Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma(TOX) | completed | Phase 2 | 50 | Milad HospitalOTHER | 1 | Mar 20, 2014 | clinicaltrials |
| NCT02090153 | Study of S-1 Plus LV for Advanced Gastric Cancer | completed | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 1 | Mar 18, 2014 | clinicaltrials |
| NCT02072317 | Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 140 | Fudan UniversityOTHER | 1 | Feb 26, 2014 | clinicaltrials |
| NCT00278863 | Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial | completed | Phase 2 | 96 | Asan Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02071043 | Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis | completed | Phase 2 | 48 | Shanghai Zhongshan HospitalOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01584336 | Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03)(KLASS-03) | unknown | Phase 2 | 168 | Soonchunhyang University HospitalOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00165594 | A Study of E7070 in Patients With Gastric Cancer | terminated | Phase 1 / Phase 2 | 50 | Eisai Co., Ltd.INDUSTRY | 1 | Jan 23, 2014 | clinicaltrials |
| NCT02038621 | The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer(GZH-001) | unknown | Phase 2 | 224 | The Second People's Hospital of SichuanOTHER | 0 | Jan 16, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01070290 | A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen | withdrawn | Phase 2 | 0 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 0 | Jan 7, 2014 | clinicaltrials |
| NCT02024217 | Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma(NEWEAR) | unknown | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Dec 31, 2013 | clinicaltrials |
| NCT00005607 | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | unknown | Phase 2 | — | Robert H. Lurie Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00719550 | AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer | completed | Phase 1 / Phase 2 | 130 | AmgenINDUSTRY | 0 | Dec 5, 2013 | clinicaltrials |
| NCT00005876 | Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery | unknown | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00464893 | Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection | completed | Phase 2 | 70 | Neovii BiotechINDUSTRY | 4 | Dec 4, 2013 | clinicaltrials |
| NCT01388790 | Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer | completed | Phase 2 | 40 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00767377 | Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC | completed | Phase 2 | 163 | Fudan UniversityOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT01963702 | A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT01180166 | Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer | unknown | Phase 2 | 30 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00088816 | S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer | unknown | Phase 2 | 50 | Kyoto UniversityOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00134095 | S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer | unknown | Phase 2 | 70 | Fukushima Medical University HospitalOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00003192 | Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | completed | Phase 2 | 15 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00632268 | Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT00009880 | Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Jul 19, 2013 | clinicaltrials |
| NCT00054249 | T900607 in Treating Patients With Gastroesophageal Junction Cancer | completed | Phase 2 | — | University Hospitals Seidman Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00166881 | Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin(P-HDFL-DI) | completed | Phase 2 | 29 | National Taiwan University HospitalOTHER | 1 | Jul 8, 2013 | clinicaltrials |
| NCT01118845 | Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma | completed | Phase 2 | 63 | SymBio PharmaceuticalsINDUSTRY | 2 | Jul 4, 2013 | clinicaltrials |
| NCT00002783 | Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer | completed | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00098527 | FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer | terminated | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01517009 | A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer(DoCCS) | completed | Phase 2 | 50 | Jeroen Bosch ZiekenhuisOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00032123 | Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00003055 | Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00003172 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00005599 | Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00006038 | Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00017056 | BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00084604 | Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00012246 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | terminated | Phase 2 | 7 | The University of Texas Medical Branch, GalvestonOTHER | 1 | May 16, 2013 | clinicaltrials |
| NCT00062257 | Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer | completed | Phase 2 | — | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | completed | Phase 2 | 52 | Seoul National University HospitalOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT01798251 | XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach | unknown | Phase 2 | 40 | Harbin Medical UniversityOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT01528501 | Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)(HDAC) | terminated | Phase 2 | 28 | Technical University of MunichOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT01836991 | D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer | unknown | Phase 2 | 200 | Zhejiang Cancer HospitalOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT01836120 | A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer | unknown | Phase 2 | 100 | Hebei Tumor HospitalOTHER | 1 | Apr 19, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 13, 2014source: clinicaltrials